Ruoxi Chen is based in New York, joined Warburg Pincus in 2011, and focuses on investments in the healthcare sector. Prior to joining Warburg Pincus, Mr. Chen worked at the Carlyle Group in the U.S. Buyout Fund, and at Citigroup. Mr. Chen is a member of the Board of Directors of Accriva Diagnostics, ComplexCare Solutions, Singular Bio, Silk Road Medical, and Vertice Pharma. He received a B.S. magna cum laude in economics and computer science from Duke University and an M.B.A. from Harvard Business School.
Years of private equity experience, deep industry knowledge, and unparalleled networks of resources enable our team of approximately 200 investment professionals to identify opportunities, attract outstanding entrepreneurs and business leaders, and ultimately partner effectively with management teams to grow successful businesses in today’s dynamic environment.